EGFR stimulation by its ligands occurs in an autocrine, paracrine or juxtracrine manner, triggering signaling pathways involved in proliferation, survival, migration, invasion and angiogenesis of primary brain cells, including tumor-initiating cells [79]. This evidence concerns the gene EGFR and neoplasm.